Patients in Europe Now Have Access to Cutting-Edge Immunotherapy in Phase II Clinical Trial

NASHVILLE, TENN., June 1, 2018 – Sarah Cannon announced today the appointment of three new research faculty to its drug development programs ...

Collaboration between Early Phase Research Leader, Sarah Cannon Research Institute and the NCI-Designated Sidney Kimmel Cancer Center – Jefferson...

NASHVILLE, TENN., May 31, 2018 – Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 85 ...

NASHVILLE, TENN., May 30, 2018 – Today, Sarah Cannon announced the promotion of William Donnellan, MD, to Director of Leukemia/Myelodysplastic...

• New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers • Collaboration will ...

NASHVILLE, Tenn., February 21, 2018 - Today, Sarah Cannon, the Cancer Institute of HCA Healthcare, announced that 18 abstracts authored by members...

Dr. Amita Patnaik and Dr. Kyriakos Papadopoulos Appointed Co-Directors of Clinical Research

Today, Sarah Cannon announced the promotion of Johanna C. Bendell, MD, to Chief Development Officer.

Sarah Cannon, the Cancer Institute of HCA Healthcare, announced today that several of its affiliated programs will participate in a new study...